337 related articles for article (PubMed ID: 29383936)
1. Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling.
Wang M; Chen DQ; Chen L; Liu D; Zhao H; Zhang ZH; Vaziri ND; Guo Y; Zhao YY; Cao G
J Agric Food Chem; 2018 Feb; 66(8):1828-1842. PubMed ID: 29383936
[TBL] [Abstract][Full Text] [Related]
2. Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis.
Wang M; Chen DQ; Chen L; Cao G; Zhao H; Liu D; Vaziri ND; Guo Y; Zhao YY
Br J Pharmacol; 2018 Jul; 175(13):2689-2708. PubMed ID: 29679507
[TBL] [Abstract][Full Text] [Related]
3. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
4. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
5. Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation.
Wang M; Hu HH; Chen YY; Chen L; Wu XQ; Zhao YY
Phytomedicine; 2020 Dec; 79():153323. PubMed ID: 32920287
[TBL] [Abstract][Full Text] [Related]
6. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.
Hoi S; Tsuchiya H; Itaba N; Suzuki K; Oka H; Morimoto M; Takata T; Isomoto H; Shiota G
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):940-946. PubMed ID: 32012313
[TBL] [Abstract][Full Text] [Related]
7. Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum.
Chen DQ; Cao G; Zhao H; Chen L; Yang T; Wang M; Vaziri ND; Guo Y; Zhao YY
Ther Adv Chronic Dis; 2019; 10():2040622319869116. PubMed ID: 31452866
[TBL] [Abstract][Full Text] [Related]
8. Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis.
Chen DQ; Wang YN; Vaziri ND; Chen L; Hu HH; Zhao YY
Phytomedicine; 2020 Jul; 72():153232. PubMed ID: 32460034
[TBL] [Abstract][Full Text] [Related]
9. Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
Huang XZ; Wen D; Zhang M; Xie Q; Ma L; Guan Y; Ren Y; Chen J; Hao CM
J Cell Biochem; 2014 May; 115(5):996-1005. PubMed ID: 24356887
[TBL] [Abstract][Full Text] [Related]
10. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic efficacy of pachymic acid in chronic kidney disease induced in rats: role of Wnt/β-catenin/renin-angiotensin axis.
Younis NN; Mohamed HE; Shaheen MA; Abdelghafour AM; Hammad SK
J Pharm Pharmacol; 2022 Jan; 74(1):112-123. PubMed ID: 34549301
[TBL] [Abstract][Full Text] [Related]
12. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling.
He X; Cheng R; Huang C; Takahashi Y; Yang Y; Benyajati S; Chen Y; Zhang XA; Ma JX
Signal Transduct Target Ther; 2020 Apr; 5(1):45. PubMed ID: 32345960
[TBL] [Abstract][Full Text] [Related]
13. Poricoic acid A suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting β-catenin K49 deacetylation.
Chen DQ; Chen L; Guo Y; Wu XQ; Zhao TT; Zhao HL; Zhang HJ; Yan MH; Zhang GQ; Li P
Acta Pharmacol Sin; 2023 May; 44(5):1038-1050. PubMed ID: 36470978
[TBL] [Abstract][Full Text] [Related]
14. Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy.
Chen L; Chen DQ; Wang M; Liu D; Chen H; Dou F; Vaziri ND; Zhao YY
Chem Biol Interact; 2017 Aug; 273():56-72. PubMed ID: 28578904
[TBL] [Abstract][Full Text] [Related]
15. ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathway in vivo and in vitro.
Wu X; Guan Y; Yan J; Liu M; Yin Y; Duan J; Wei G; Hu T; Weng Y; Xi M; Wen A
J Pharm Pharmacol; 2015 Aug; 67(8):1054-65. PubMed ID: 25864844
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signaling pathway contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury and is possibly related to the transforming growth factorβ1/Smad3 signaling pathway.
Zhang G; Ge M; Han Z; Wang S; Yin J; Peng L; Xu F; Zhang Q; Dai Z; Xie L; Li Y; Si J; Ma K
Biomed Pharmacother; 2019 Feb; 110():420-430. PubMed ID: 30530044
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype.
Anorga S; Overstreet JM; Falke LL; Tang J; Goldschmeding RG; Higgins PJ; Samarakoon R
FASEB J; 2018 May; 32(5):2644-2657. PubMed ID: 29298862
[TBL] [Abstract][Full Text] [Related]
18. Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation.
Xu L; Cui WH; Zhou WC; Li DL; Li LC; Zhao P; Mo XT; Zhang Z; Gao J
J Cell Mol Med; 2017 Aug; 21(8):1545-1554. PubMed ID: 28244647
[TBL] [Abstract][Full Text] [Related]
19. GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF-β-Induced Smad3 Phosphorylation.
Ai J; Nie J; He J; Guo Q; Li M; Lei Y; Liu Y; Zhou Z; Zhu F; Liang M; Cheng Y; Hou FF
J Am Soc Nephrol; 2015 Aug; 26(8):1827-38. PubMed ID: 25392233
[TBL] [Abstract][Full Text] [Related]
20. Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-
Liu P; Wang C; Wang Y; Zhang H; Liu B; Qiu X
Biomed Res Int; 2021; 2021():2793823. PubMed ID: 34938805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
